European Commission approves CAR T therapy for lymphoma

CAR T-cell therapy Breyanzi has been approved by the European Commission (EC) based on significant results from a lymphoma Phase III trial.

Related Keywords

Berlin ,Germany ,Switzerland ,Canada ,Japan ,Anne Kerber ,Bristol Myers Squibb ,Head Of Cell Therapy Development ,European Commission ,Physician Of The Department Hematology ,Chief Physician ,Stem Cell Transplantation ,Helios Klinikum ,Senior Vice President ,Cell Therapy Development ,Bristol Myers ,Myers Squibb ,